Lumiradx Ltd. -CW26LMDWFPreferred / convertible
13F holders, Q1 2024 (March 31)4holders
$0.01avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Lumiradx Ltd. -CW26 (LMDWF) in their 13F filings. The largest holders were CVS HEALTH Corp ($41K), Goldman Sachs Group Inc. ($2K) and Ancora Advisors LLC ($63).
- Company
- Lumiradx Ltd. -CW26
- CUSIP
- G5709L117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 12 | $6K |
Ownership 4 holders
| CVS HEALTH Corp | — | No change | 5,352,106 | $41K |
| Goldman Sachs Group Inc. | — | No change | 215,680 | $2K |
| Ancora Advisors LLC | — | No change | 15,470 | $63 |
| Steward Partners Investment Advisory, LLC | — | No change | 21 | $0 |
"% of holder's portfolio" is LMDWF's weight in each manager's 13F, not the share of Lumiradx Ltd. -CW26 the manager owns.